These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 16895161

  • 1. Consultation and management of patients with lipid disorders: importance of life-style changes and intensive follow-up.
    Karwacki-Marugg CL, Schnatz JD.
    Conn Med; 2006 Mar; 70(3):133-9. PubMed ID: 16895161
    [Abstract] [Full Text] [Related]

  • 2. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial.
    Grover SA, Lowensteyn I, Joseph L, Kaouache M, Marchand S, Coupal L, Boudreau G, Cardiovascular Health Evaluation to Improve Compliance and Knowledge Among Uninformed Patients (CHECK-UP) Study Group.
    Arch Intern Med; 2007 Nov 26; 167(21):2296-303. PubMed ID: 18039987
    [Abstract] [Full Text] [Related]

  • 3. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
    Coodley GO, Jorgensen M, Kirschenbaum J, Sparks C, Zeigler L, Albertson BD.
    Am J Med; 2008 Jul 26; 121(7):604-10. PubMed ID: 18538295
    [Abstract] [Full Text] [Related]

  • 4. [Development of cardiovascular risk factors in patients after coronary artery bypass grafting with an in-hospital rehabilitation programme (WHO Stage I of Rehabilitation): 1-year follow-up].
    Schimmer C, Krannich JH, Brauchle-Hopp U, Elert O.
    Rehabilitation (Stuttg); 2006 Apr 26; 45(2):95-101. PubMed ID: 16575715
    [Abstract] [Full Text] [Related]

  • 5. Clinical impact of a pharmacist-physician co-managed programme on hyperlipidaemia management in Hong Kong.
    Lee VW, Fan CS, Li AW, Chau AC.
    J Clin Pharm Ther; 2009 Aug 26; 34(4):407-14. PubMed ID: 19583673
    [Abstract] [Full Text] [Related]

  • 6. Lipids.
    Beattie S.
    RN; 2009 Sep 26; 72(9):16-8, 20-1. PubMed ID: 19839095
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of long-term cardiac training on lipids concentration in patients with chronic heart ischemic disease treated with simvastatin].
    Kałka D, Sobieszczańska M, Kopka L, Marciniak W, Zawadzka-Bartczak E, Bak A, Popielewicz-Kautz A, Korzeniowska J, Janczak J, Adamus J.
    Pol Merkur Lekarski; 2007 Feb 26; 22(128):101-6. PubMed ID: 17598652
    [Abstract] [Full Text] [Related]

  • 8. Management of dyslipidemia.
    Akel MM, Salti I.
    J Med Liban; 2001 Feb 26; 49(5):274-8. PubMed ID: 12243421
    [No Abstract] [Full Text] [Related]

  • 9. Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?
    Sarawate CA, Cziraky MJ, Stanek EJ, Willey VJ, Corbelli JC, Charland SL.
    Clin Ther; 2007 Jan 26; 29(1):196-209. PubMed ID: 17379061
    [Abstract] [Full Text] [Related]

  • 10. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S.
    Am J Cardiol; 2009 Jan 01; 103(1):41-5. PubMed ID: 19101227
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effectiveness of a fenofibrate 145-mg nanoparticle tablet formulation compared with the standard 160-mg tablet in patients with coronary heart disease and dyslipidemia.
    Maciejewski S, Hilleman D.
    Pharmacotherapy; 2008 May 01; 28(5):570-5. PubMed ID: 18447655
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.
    Sachdeva A, Cannon CP, Deedwania PC, Labresh KA, Smith SC, Dai D, Hernandez A, Fonarow GC.
    Am Heart J; 2009 Jan 01; 157(1):111-117.e2. PubMed ID: 19081406
    [Abstract] [Full Text] [Related]

  • 15. Management of hyperlipidemia.
    Low Dog T, Riley D.
    Altern Ther Health Med; 2003 Jan 01; 9(3):28-40; quiz 41. PubMed ID: 12776473
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS.
    Clin Ther; 2007 Nov 01; 29(11):2365-73. PubMed ID: 18158077
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The lipid management nutrition outcomes project: perspectives from a national experience in protocol implementation and nutrition outcomes tracking.
    Rhodes KS, Weintraub MS, Biesemeier CK, Rubenfire M.
    J Am Diet Assoc; 2008 Feb 01; 108(2):332-9. PubMed ID: 18237579
    [Abstract] [Full Text] [Related]

  • 19. Lipid profile of term infants on exclusive breastfeeding and mixed feeding: a comparative study.
    Harit D, Faridi MM, Aggarwal A, Sharma SB.
    Eur J Clin Nutr; 2008 Feb 01; 62(2):203-9. PubMed ID: 17327867
    [Abstract] [Full Text] [Related]

  • 20. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE.
    J Cardiovasc Pharmacol; 2008 Apr 01; 51(4):331-51. PubMed ID: 18427276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.